Choose from our industry specialties


Get more qualified clients using Facebook

The Numbers don't lie

Live up to date stat reporting for going Uloric rates (Jul 1 - Jul 31, 2019)

When Uloric was first approved in 2009, the FDA required the drug manufacturer, Takeda, to conduct a large postmarket safety clinical trial in more than 6,000 patients with gout treated with either Uloric or allopurinol. The primary outcome revealed increased risk of heart-related death, heart attack, stroke and unstable angina which is a condition where there is inadequate blood supply to the heart requiring surgical intervention.

Get Started


Our Goal is to see you succeed. Read what our clients have to say about the X Social Media experience.

Contact Us

Call us (888) 670-0006 or email us on the online form

    © 2022 X Social Media All rights reserved